Objectives A new variant of Chlamydia trachomatis (nvCT) was discovered in Sweden in late 2006. The nvCT has a plasmid deletion, which escaped detection by two nucleic acid amplification tests that were being used in 14 of 21 Swedish counties. The objectives of this study were to assess when and where nvCT emerged in Sweden, the proportion of nvCT in each county, and the role of a potential fitness difference between nvCT and the cocirculating wtCT strains.
was between 20% and 65% in counties using the Abbott/Roche (AR) NAATs, compared with 7%-19% in counties using the BD NAAT. 3 Testing of archived specimens found the earliest evidence of nvCT in Örebro (central with versions that detect nvCT in AR counties, the proportion of nvCT had decreased to 5%-7% by 2015 in all counties, irrespective of the NAAT used. 7 The studies published so far leave open questions about the dynamics of the emergence, spread and decline of nvCT. The timing and place of its emergence remain unknown. It is assumed that a single genetic event produced the new variant, which initially co-existed with the wild type CT (wtCT) and then spread clonally, evading detection in areas that used AR tests. 5 Extensive genomic comparisons and analyses of morphology, in vitro growth kinetics, phenotypic characteristics including antimicrobial susceptibility, and cell tropism did not detect any differences in fitness characteristics between any examined wtCT strain and nvCT. 5 At the population level, the fitness of a CT strain can be expressed as the average number of secondary infections caused by an infected individual, i.e., the basic reproduction number R0. 8 Hence, differences in the relative transmissibility or infectious duration of a strain would result in a either a fitness cost or benefit. 9 So far, the available data could not 4 determine the relative contributions of potentially altered transmission, patterns of sexual mixing between people infected with wtCT and nvCT, and changes in testing to the observed nationwide increase and subsequent decrease in the proportion of nvCT. 10 The objectives of this study were to assess when and where nvCT emerged in Sweden, the proportion of nvCT in each county, and the role of a potential fitness difference between nvCT and the co-circulating wtCT strains. To this end, we developed a mathematical model of CT transmission that was fitted to surveillance data about reported diagnoses of chlamydia infection in each county, and data from four counties that assessed the proportion of nvCT in multiple years, using Bayesian inference.
METHODS

Data
We used data on the type of NAAT used in Swedish counties. From the mid-nineties, chlamydia cell culture was replaced by NAAT. In 13 of 21 Swedish counties, AR NAATs were used, in seven counties, the BD NAAT system was used and one county, Västra Götaland, used the BD NAAT in three of four laboratories and an AR NAAT in a single smaller laboratory. We refer to counties according to the NAAT system used, with the suffix -AR or -BD. In the model, Västra Götaland is treated as a BD county.
We used published data about the proportion of nvCT and data about diagnosis rates in Table S1 ). 7 We had data about the yearly number of CT diagnoses from all counties since 1997. 11 In the model, we only used CT diagnosis data from Dalarna, Örebro, Uppsala and Norrbotten for selected years before and after the discovery of nvCT (2004, 2006, 2007, 2008 and 2009 , Table S2 ).
We chose this subset of data to give the diagnoses rates and the data about the proportion of nvCT a similar weight for Bayesian inference. We also anticipated that those differences in diagnosis rates between AR counties and BD counties, attributable to misdiagnoses by AR NAAT before the discovery of nvCT, would be most pronounced in years around its discovery. For simplicity, we assumed that only people aged 15-29 years old were tested. We 5 calculated the diagnosis rate for this population by dividing the total number of diagnoses by the county-specific yearly population sizes for this age group. Population sizes were obtained from Statistics Sweden. 12 We used spatial data specifying distances between the centroids of the counties, which we downloaded as a geographic information system shapefile. Lastly, we used sexual behaviour data about the yearly number of new heterosexual partners for sexually experienced people from 15 to 29 years. These data were from the second British National Survey of Sexual Attitudes and Lifestyles (Natsal-2) because there were no detailed sexual behaviour data from Sweden. Natsal-2 is a nationally representative cross-sectional survey that interviewed 12,110 respondents aged 16-44 years (response rate 65.4%) from 1999 to 2001. 13 
Transmission model
We developed a mathematical model to describe the spread of nvCT in Sweden. The model is a deterministic compartmental model based on a set of ordinary differential equations where individuals can be infected with either wtCT or nvCT. We assumed that wtCT is representative of all CT strains that are co-circulating with nvCT. Model parameters are shown in table 1 and a detailed description of the model is given in the Supplementary Material S1.
We implemented the spatial structure of the 21 Swedish counties into a meta-population model, 14 and considered the population of 15-29 year old Swedish sexually experienced heterosexual adults, subdivided into a low and a high sexual activity class (figure S1).
Susceptible people seek sexual partners at rate c. The per partnership transmission probability of wtCT and nvCT is and , respectively, where can account for a potential difference in transmissibility of nvCT. Infected people clear infection naturally at rate , or receive treatment. The treatment rate depends on the year, county and on whether the person is infected with wtCT or nvCT.
We assumed that wtCT infected people in all counties are treated at a fixed rate before October 2006. nvCT infected people are treated at the same rate in BD counties, whereas they are not treated in AR counties. We assumed that after October 2006, when nvCT was discovered and the AR tests were modified, all people with diagnosed CT were treated. The increased number of tests after 2006 (Supplementary Material, figure S2 ) and reported 6 diagnosis rates suggest a higher treatment rate directly after the discovery of nvCT. 10 We modelled this by assuming that the treatment rate is a certain percentage ( ) higher than directly after the discovery of nvCT, and that this percentage decreases linearly to zero within 3 years. We assumed sexual mixing between activity classes from proportionate ( = 0) to assortative ( = 0). In the meta-population structure, mixing between individuals from different counties was modelled using a gravity model, i.e., mixing between counties is positively associated with the population size and inversely related to the distance between 7 counties. 15 The level of within-county mixing was set using previously published algebraic functions. 16 
Bayesian inference
We ran the model for 30 years to approach equilibrium in the absence of nvCT. We then simulated the emergence of nvCT in county by assuming that 1% of prevalent CT cases in steady state change from wtCT to nvCT. We then set the time to Δ years before the discovery of nvCT and ran the model until 2015. We obtained posterior distributions of the model parameters by fitting the model to data about the proportions of nvCT and all CT diagnoses using Bayesian inference. We used Markov Chain Monte Carlo (MCMC) sampling with a Metropolis Hasting algorithm to do this. We considered emergence of nvCT in each county which resulted in 21 model versions. We then used the deviance information criterion (DIC) 17, 18 to compare between the model fits and identify the most likely county for the emergence of nvCT.
Sensitivity analyses
We investigated the alternative assumption that a fitness difference between wtCT and nvCT strains is associated with a relative difference in infectious duration instead of a relative difference in transmissibility. The observed CT diagnosis rates in AR counties were much higher after the discovery of nvCT than before ( figure 2C ). This observation could reflect increased chlamydia prevalence after emergence of nvCT because people in AR counties with undiagnosed nvCT did not receive treatment until 2006. In the model, CT prevalence in Dalarna increased almost three-fold.
RESULTS
The model version in which nvCT emerged in
Alternatively, the diagnosis rate might result from additional chlamydia testing after 2006.
The parameter (increase in testing rate after discovery of nvCT) in the model represents increased testing. However, was estimated at close to zero so, in the model, increased diagnoses rates reflect increased transmission rather than diagnosis.
From 2007, the proportion of nvCT and the diagnosis rates decreased in all counties. We estimated that nvCT was 5% (BCI: 4-6%) less transmissible than wtCT strains. In the sensitivity analysis where we assumed that the fitness cost could also be associated with infectious duration, we estimated a 17% (BCI: 16-19%) reduction in infectious duration for nvCT compared to wtCT strains (Supplementary Material, figure S4 ). In both cases, the 11 reduced fitness of nvCT and its dilution across counties, together with the loss of the diagnostic selective advantage, led to the decline in its proportion after its discovery. This process can also be quantified by R0, which we computed for wtCT and nvCT in presence and absence of effective testing and treatment (Supplementary Material S3). R0 for wtCT is slightly above the threshold of one (1.06, BCI: 1.04-1.06). R0 for nvCT before its discovery is considerably higher (4.06, BCI: 3.62-4.37), owing to the diagnostic selective advantage of nvCT compared with wtCT. In contrast, R0 for nvCT after its discovery is lower (1.00, BCI:
0.99-1.02), owing to its reduced transmissibility and the lost diagnostic selective advantage. Our modelling results suggests that this decline is consistent with the lost diagnostic selective advantage of nvCT and a fitness cost. We estimated that this fitness cost reduced the transmissibility by around 5%, or the infectious duration by around 17%.
DISCUSSION
The strengths of the model are that it is relatively simple, but incorporates necessary heterogeneity in mixing between groups with differing levels of sexual activity and between different geographical areas. There were sufficient empirical data about the proportion of nvCT after its discovery and more detailed data in both AR and BD counties to fit the model.
Our study also has a number of limitations that need to be considered when interpreting the findings. First, because of its simplicity, the model can estimate changes in the proportion of nvCT well but cannot generate reliable estimates of incidence and prevalence. Describing changes in tests over time accurately whilst keeping model-predicted prevalence at credible levels would require a more sophisticated model. The detailed data needed to parameterise a model with more heterogeneity in sexual behaviour and test uptake were not available.
Second, we did not model the possibility that factors other than the spread of nvCT, such as increased incidence or changes in screening policy, might have contributed to an increase in 12 overall CT prevalence in Sweden. 19 We had insufficient data to parameterise such a model, and this was not one of the objectives of the study. Third, we used a deterministic model.
While rather unlikely, nvCT could have emerged independently in multiple unrelated people, possibly in different counties and at different times. Modelling these possibilities in more detail would require a stochastic modelling framework. The choice of a deterministic model did not affect parameter inference, because we only used data for years when there was a substantial proportion of nvCT. Modelling stochasticity in these circumstances is less important. 14 Furthermore, extensive genotyping of nvCT cases from different time points and countries support a clonal spread of nvCT. 3, 7, 20, 21 The emergence of nvCT is, to our knowledge, the first reported example of a strain mutating to escape detection by a diagnostic test. This unique event in the field of diagnostics can be compared to the mechanisms that facilitate the spread of antimicrobial resistance for other sexually transmitted infections. We found that high CT treatment rates contributed to the spread of nvCT in Sweden. Modelling studies of the spread of antimicrobial resistance in
Neisseria gonorrhoeae have identified high treatment rates as the major driver for the spread of resistance. 9, 22 Antimicrobial resistance in CT has not been detected yet, but its possible emergence cannot be excluded with continued antimicrobial selection pressure. 23 Our estimate that around three quarters of infected people receives treatment (Supplementary Material, S5) is consistent with the history of early introduction of widespread opportunistic testing and an advanced system of partner notification that identifies recent sex partners with a high probability of CT. 24, 25 The insights into the means by which competition between CT strains, through selection pressure induced by testing and treatment, can inform the future study of the potential for the spread of antimicrobial resistance in CT.
This modelling study provides insights into the spread of nvCT in Sweden that are consistent . 5 In addition, our study indicates that nvCT is associated with a fitness cost that results in reduced transmission at the population level. In vitro studies showed that nvCT had unaltered fitness compared to all examined wtCT strains. 5 However, small-scale gene 13 variations and/or alterations in timing and level of gene transcription and translation, that result in small reductions in growth in vivo, could not be excluded. 5 Also, fitness as measured by in vitro growth assays is not necessarily related to fitness at the population level, as expressed by R0. Our study shows the value of high quality surveillance data and of the prompt investigation and follow up of anomalies in these data. In conclusion, our model results quantified the speed of spread of C. trachomatis in the absence of testing and treatment. The results of this mathematical modelling study, incorporating surveillance data, improved our understanding of the epidemic caused by nvCT in Sweden. 14 
